prednisolone has been researched along with Adenocarcinoma of Lung in 6 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prednisolone was administered orally, after which the biliary tract and hepatic enzyme levels improved immediately." | 1.62 | Atezolizumab-induced Sclerosing Cholangitis in a patient with lung cancer: A case report. ( Hattori, N; Kawamoto, K; Matsumoto, N; Nabeshima, S; Nishi, Y; Ohashi, N; Takaki, S; Taniwaki, M; Yamasaki, M, 2021) |
| "We herein report a case of immune-related colitis induced by the long-term use of nivolumab." | 1.48 | Immune-related Colitis Induced by the Long-term Use of Nivolumab in a Patient with Non-small Cell Lung Cancer. ( Hattori, Y; Ito, S; Kawa, Y; Kono, Y; Negoro, S; Sakuma, T; Satouchi, M; Tohnai, R; Tsuda, M; Urata, Y; Yasuda, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Horie, K | 1 |
| Asakura, T | 1 |
| Masuzawa, K | 1 |
| Terai, H | 1 |
| Nakayama, S | 1 |
| Suzuki, Y | 1 |
| Hisamatsu, Y | 1 |
| Morinaga, R | 1 |
| Watanabe, E | 1 |
| Ohtani, S | 1 |
| Shirao, K | 1 |
| Cho, SL | 1 |
| Lin, WC | 1 |
| Chuang, CA | 1 |
| Liao, WY | 1 |
| Lai, CF | 1 |
| McClure, T | 1 |
| Cui, W | 1 |
| Asadi, K | 1 |
| John, T | 1 |
| Testro, A | 1 |
| Nabeshima, S | 1 |
| Yamasaki, M | 1 |
| Matsumoto, N | 1 |
| Takaki, S | 1 |
| Nishi, Y | 1 |
| Kawamoto, K | 1 |
| Taniwaki, M | 1 |
| Ohashi, N | 1 |
| Hattori, N | 1 |
| Yasuda, Y | 1 |
| Urata, Y | 1 |
| Tohnai, R | 1 |
| Ito, S | 1 |
| Kawa, Y | 1 |
| Kono, Y | 1 |
| Hattori, Y | 1 |
| Tsuda, M | 1 |
| Sakuma, T | 1 |
| Negoro, S | 1 |
| Satouchi, M | 1 |
6 other studies available for prednisolone and Adenocarcinoma of Lung
| Article | Year |
|---|---|
ALK-positive lung adenocarcinoma in a patient with rheumatoid arthritis with long-term treatment for organizing pneumonia: A case report.
Topics: Adenocarcinoma of Lung; Aged, 80 and over; Arthritis, Rheumatoid; Dyspnea; Female; Humans; Inflammat | 2022 |
Febrile Neutropenia in a Patient with Non-Small Cell Lung Cancer Treated with the Immune-Checkpoint Inhibitor Nivolumab.
Topics: Adenocarcinoma of Lung; Adrenal Gland Neoplasms; Antineoplastic Agents, Immunological; Brain Neoplas | 2020 |
Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Biopsy; Erlotinib Hydrochloride; Glucocorticoid | 2020 |
Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up.
Topics: Adenocarcinoma of Lung; Administration, Oral; Aged; Biopsy; Cholangiopancreatography, Magnetic Reson | 2020 |
Atezolizumab-induced Sclerosing Cholangitis in a patient with lung cancer: A case report.
Topics: Adenocarcinoma of Lung; Administration, Oral; Aged; Antibodies, Monoclonal, Humanized; Bile Ducts; C | 2021 |
Immune-related Colitis Induced by the Long-term Use of Nivolumab in a Patient with Non-small Cell Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Asian P | 2018 |